CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 228 enrolled
Drug / intervention
Angal, lozenges [menthol], +1 moredrug
Likely dose
ANTI-ANGIN® FORMULA 0,2 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03095521
NCT03095521Phase 3Completed
CompareCT.gov

A Prospective, Multi-center, Open, Randomized Clinical Study in Parallel Groups, for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol], 1 mg + 5 mg (Sandoz d.d., Slovenia), and ANTI-ANGIN® FORMULA, Lozenges, 0,2 mg + 2 mg + 50 mg (LLC "Valeant", Russia) in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat.

Sandoz·interventional·Posted Mar 29, 2017·Updated Mar 22, 2019

In Brief

A Phase 3 clinical trial evaluating Angal, lozenges [menthol], and ANTI-ANGIN® FORMULA for Sore Throat. Completed, enrolled 228 participants across 14 sites.

Detailed Summary

The purpose of this study was to evaluate no less therapeutic efficacy and safety of the Angal, lozenges \[Menthol\], 1 mg + 5 mg (Sandoz dd, Slovenia) compared to ANTI-ANGIN® FORMULA, lozenges, 0,2 mg + 2 mg + 50 mg (LLC "Valeant", Russia) in treatment of patients with uncomplicated acute infectious and inflammatory diseases of the pharynx, accompanied by a sore throat.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSore Throat
CountriesRussia
Collaborators--

Timeline

Phase 3CompletedFinished
2017201820192020202120222023202420252026
First PostedMar 29, 2017
Enrollment StartFeb 22, 2017
Primary CompletionMay 7, 2017
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.3 years ago

Interventions

Angal, lozenges [menthol],drug

Angal, administered per 1 lozenge, with an interval 2 hours or more, 6-10 lozenges per day, for a maximum 4 days or until full illness resolution.

ANTI-ANGIN® FORMULAdrug

0,2 mg + 2 mg + 50 mg (LLC "Valeant", Russia). Administered per 1 lozenge, with an interval 2 hours or more, up to 6 lozenges per day, for a maximum 5 days or until full illness resolution.